National Notifiable Diseases Surveillance System, 1 April to 30 June 2013

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in <em>Communicable Diseases Intelligence.</em> This page contains a table on notifiable diseases reported from each state or territory for the reporting period 1 April to 30 June 2013.

Page last updated: 21 February 2014


A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 104,327 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 April and 30 June 2013 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).
NEC - Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
All jurisdictions
Hepatitis B (newly acquired)
All jurisdictions
Hepatitis B (unspecified)
All jurisdictions
Hepatitis C (newly acquired)
All jurisdictions except Queensland
Hepatitis C (unspecified)
All jurisdictions
Hepatitis D
All jurisdictions
Gastrointestinal diseases
Botulism
All jurisdictions
Campylobacteriosis
All jurisdictions except New South Wales
Cryptosporidiosis
All jurisdictions
Haemolytic uraemic syndrome
All jurisdictions
Hepatitis A
All jurisdictions
Hepatitis E
All jurisdictions
Listeriosis
All jurisdictions
STEC, VTEC*
All jurisdictions
Salmonellosis
All jurisdictions
Shigellosis
All jurisdictions
Typhoid
All jurisdictions
Quarantinable diseases
Cholera
All jurisdictions
Highly pathogenic avian influenza in humans
All jurisdictions
Plague
All jurisdictions
Rabies
All jurisdictions
Severe acute respiratory syndrome
All jurisdictions
Smallpox
All jurisdictions
Viral haemorrhagic fever
All jurisdictions
Yellow fever
All jurisdictions
Sexually transmissible infections
Chlamydial infection
All jurisdictions
Donovanosis
All jurisdictions
Gonococcal infection
All jurisdictions
Syphilis - congenital
All jurisdictions
Syphilis <2 years duration
All jurisdictions
Syphilis >2 years or unspecified duration
All jurisdictions
Vaccine preventable diseases
Diphtheria
All jurisdictions
Haemophilus influenzae type b
All jurisdictions
Influenza (laboratory confirmed)
All jurisdictions
Measles
All jurisdictions
Mumps
All jurisdictions
Pertussis
All jurisdictions
Pneumococcal disease (invasive)
All jurisdictions
Poliomyelitis
All jurisdictions
Rubella
All jurisdictions
Rubella - congenital
All jurisdictions
Tetanus
All jurisdictions
Varicella zoster (chickenpox)
All jurisdictions except New South Wales
Varicella zoster (shingles)
All jurisdictions except New South Wales
Varicella zoster (unspecified)
All jurisdictions except New South Wales
Vectorborne diseases
Arbovirus infection (NEC)
All jurisdictions
Barmah Forest virus infection
All jurisdictions
Dengue virus infection
All jurisdictions
Japanese encephalitis virus infection
All jurisdictions
Kunjin virus infection
All jurisdictions
Malaria
All jurisdictions
Murray Valley encephalitis virus infection
All jurisdictions
Ross River virus infection
All jurisdictions
Zoonoses
Anthrax
All jurisdictions
Australian bat lyssavirus
All jurisdictions
Brucellosis
All jurisdictions
Leptospirosis
All jurisdictions
Lyssavirus (NEC)
All jurisdictions
Ornithosis
All jurisdictions
Q fever
All jurisdictions
Tularaemia
All jurisdictions
Other bacterial infections
Legionellosis
All jurisdictions
Leprosy
All jurisdictions
Meningococcal infection
All jurisdictions
Tuberculosis
All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 April to 30 June 2013, by date of diagnosis*
  State or territory Total this quarter 2013 Total last quarter 2012 Total this quarter 2012 Last 5 years mean this quarter Ratio Year to date 2013 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas Vic WA
* Date of diagnosis = the true diagnosis. If this is not available, the ‘date of onset’ is equivalent to the earliest of two dates: (i) specimen date of collection, or (ii) the date of notification to the public health unit. Hepatitis B and C unspecified were analysed by the date of notification.

† Newly-acquired hepatitis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.

§ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.

ll In the national case definitions for chlamydial, gonococcal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.

** Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.

Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)
1
9
2
10
2
0
14
6
44
45
34
55.4
0.8
89
113.0
Hepatitis B (unspecified)
19
567
155
194
77
18
457
280
1,767
1,645
1,583
1,624.0
1.1
3,402
3,305.4
Hepatitis C (newly acquired)
2
2
0
NN
10
6
22
24
66
108
116
106.0
0.6
172
207.8
Hepatitis C (unspecified)
48
835
98
594
86
48
469
306
2,484
2,464
2,248
2,581.2
1.0
4,937
5,234.0
Hepatitis D
0
3
0
5
1
0
6
1
16
14
10
11.2
1.4
30
20.6
Gastrointestinal diseases
Botulism
0
0
0
0
0
0
1
0
1
2
0
0.2
5.0
3
0.4
Campylobacteriosis
70
NN
61
792
432
136
1,338
364
3,193
3,515
3,270
3,591.4
0.9
6,667
8,131.6
Cryptosporidiosis
12
290
33
210
49
19
379
125
1,117
1,736
919
684.0
1.6
2,842
1,930.2
Haemolytic uraemic syndrome
0
0
1
0
0
0
1
0
2
4
5
4.0
0.5
6
9.2
Hepatitis A
0
11
0
10
1
0
14
6
42
70
37
74.2
0.6
110
142.6
Hepatitis E
0
4
0
1
0
0
1
0
6
15
8
9.6
0.6
21
24.0
Listeriosis
0
7
0
3
1
0
4
2
17
29
21
17.2
1.0
46
44.6
STEC, VTEC§
0
6
0
5
11
0
3
1
26
45
23
18.2
1.4
71
50.6
Salmonellosis
114
844
93
608
270
54
712
334
3,029
4,190
2,454
2,423.6
1.2
7,180
6,225.2
Shigellosis
2
20
32
22
5
0
25
9
115
145
119
138.8
0.8
258
332.2
Typhoid
0
17
0
5
0
0
6
1
29
69
21
24.0
1.2
97
67.2
Quarantinable diseases
Cholera
0
0
0
0
0
0
1
0
1
0
4
1.8
0.6
1
2.6
Highly pathogenic avian influenza in humans
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
1.0
0.0
0
1.0
Sexually transmissible infections
Chlamydial infection||,¶
334
5,099
745
4,778
1,346
429
4,992
3,019
20,742
21,045
20,359
18,272.0
1.1
41,633
36,763.6
Donovanosis
0
0
0
0
0
0
0
0
0
0
0
0.4
0.0
0
0.6
Gonococcal infection||
22
1,042
523
717
262
22
775
472
3,835
3,768
3,454
2,713.2
1.4
7,564
5,361.2
Syphilis – congenital
0
2
0
0
0
0
0
0
2
1
0
0.6
3.3
3
1.8
Syphilis < 2 years duration||
1
121
3
61
20
4
142
23
375
443
395
337.4
1.1
815
688.8
Syphilis > 2 years or unspecified duration‡,||
4
105
49
50
26
3
135
64
436
403
308
329.0
1.3
834
664.0
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0
0
0
1
0
0.8
0.0
1
0.8
Haemophilus influenzae type b
0
2
0
2
0
0
1
0
5
3
4
6.8
0.7
8
11.2
Influenza (laboratory confirmed)
58
269
38
649
421
12
494
209
2,510
2,341
7,338
5,624.6
0.4
4,824
6,687.4
Measles
0
9
0
4
1
0
3
0
17
10
31
22.4
0.8
27
65.2
Mumps
1
33
0
12
0
1
2
9
58
74
69
46.4
1.3
131
105.4
Pertussis
37
501
28
834
137
88
589
322
2,536
3,634
5,384
5,709.4
0.4
6,137
12,435.8
Pneumococcal disease (invasive)
5
135
12
86
35
7
104
54
438
214
505
462.0
0.9
652
678.0
Poliomyelitis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
0
4
0
1
1
0
1
0
7
2
9
10.2
0.7
9
23.0
Rubella – congenital
0
0
0
0
1
0
0
0
1
0
0
0.0
0.0
1
0.0
Tetanus
0
1
0
0
0
0
0
0
1
3
0
0.6
1.7
4
2.4
Varicella zoster (chickenpox)
1
NN
19
48
101
8
176
80
433
373
458
401.2
1.1
804
755.0
Varicella zoster (shingles)
20
NN
66
8
490
51
290
339
1,264
1,210
1,119
805.8
1.6
2,460
1,646.8
Varicella zoster (unspecified)
30
NN
1
1,196
34
23
658
297
2,239
2,279
2,037
1,630.2
1.4
4,480
3,284.6
Vectorborne diseases
Arbovirus infection (NEC)
0
0
0
5
0
0
0
0
5
5
3
2.4
2.1
10
5.8
Barmah Forest virus infection
1
133
168
828
23
2
24
361
1,540
1,427
332
387.8
4.0
2,959
1,012.4
Dengue virus infection
1
68
14
182
15
3
94
118
495
489
419
220.4
2.2
980
697.6
Japanese encephalitis virus infection
0
0
0
0
1
0
0
1
2
0
0
0.0
0.0
2
0.2
Kunjin virus infection
0
0
0
0
0
0
0
0
0
0
0
0.4
0.0
0
1.0
Malaria
2
14
2
24
2
5
18
18
85
137
73
104.6
0.8
222
212.6
Murray Valley encephalitis virus infection
0
0
0
0
0
0
0
0
0
0
0
2.0
0.0
0
4.4
Ross River virus infection
0
197
72
595
36
1
34
363
1,298
1,349
1,199
1,345.0
1.0
2,642
3,617.4
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Australian bat lyssavirus
0
0
0
0
0
0
0
0
0
1
0
0.0
0.0
1
0.0
Brucellosis
0
0
0
4
0
0
0
0
4
6
3
8.0
0.5
9
15.8
Leptospirosis
0
3
2
32
0
0
1
1
39
16
47
43.4
0.9
54
104.0
Lyssavirus (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
4
0
0
0
0
11
0
15
8
15
18.8
0.8
22
36.0
Q fever
0
45
0
77
3
0
15
2
142
97
81
81.6
1.7
238
177.0
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.5
Other bacterial infections
Legionellosis
0
29
1
29
13
2
15
22
111
99
89
89.8
1.2
208
164.0
Leprosy
0
0
1
0
0
0
0
2
3
2
1
2.0
1.5
5
3.4
Meningococcal infection**
1
6
1
9
5
0
3
3
28
39
67
61.4
0.5
67
106.4
Tuberculosis
3
104
9
43
9
0
83
31
282
309
270
278.4
1.0
589
580.2
Total
789
10,901
2,229
12,733
3,927
942
12,113
7,269
50,903
53,884
54,941
   
104,327
 

Top of page

Table 3: Notification rates of diseases, 1 April to 30 June 2013, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
* Date of Diagnosis = the true diagnosis. If this is not available, the ‘date of onset’ is equivalent to the earliest of two dates: (i) specimen date of collection, or (ii) the date of notification to the public health unit. Hepatitis B and C unspecified were analysed by the date of notification.

† Rate per 100,000 of population. Annualisation factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.

|| Infection with Shiga-like toxin (verotoxin) producing Escherichia coli.

¶ In the national case definitions for chlamydial, gonococcal and syphilis infections the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode (e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular infections are excluded, and Western Australia also excludes perinatal infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.

Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)
1.1
0.5
3.4
0.9
0.5
0.0
1.0
1.0
0.8
Hepatitis B (unspecified)§
20.3
31.1
263.6
17.0
18.6
14.1
32.5
46.0
31.1
Hepatitis C (newly acquired)
2.1
0.1
0.0
NN
2.4
4.7
1.6
3.9
1.5
Hepatitis C (unspecified)§
51.2
45.7
166.7
52.0
20.8
37.5
33.3
50.3
43.8
Hepatitis D
0.0
0.2
0.0
0.4
0.2
0.0
0.4
0.2
0.3
Gastrointestinal diseases
Botulism
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Campylobacteriosis
74.7
NN
103.7
69.4
104.3
106.2
95.1
59.9
82.9
Cryptosporidiosis
12.8
15.9
56.1
18.4
11.8
14.8
26.9
20.6
19.7
Haemolytic uraemic syndrome
0.0
0.0
1.7
0.0
0.0
0.0
0.1
0.0
0.0
Hepatitis A
0.0
0.6
0.0
0.9
0.2
0.0
1.0
1.0
0.7
Hepatitis E
0.0
0.2
0.0
0.1
0.0
0.0
0.1
0.0
0.1
Listeriosis
0.0
0.4
0.0
0.3
0.2
0.0
0.3
0.3
0.3
STEC,VTEC||
0.0
0.3
0.0
0.4
2.7
0.0
0.2
0.2
0.5
Salmonellosis
121.6
46.2
158.2
53.3
65.2
42.2
50.6
54.9
53.4
Shigellosis
2.1
1.1
54.4
1.9
1.2
0.0
1.8
1.5
2.0
Typhoid fever
0.0
0.9
0.0
0.4
0.0
0.0
0.4
0.2
0.5
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Human pathogenic avian influenza in humans
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydial infection¶,**
356.4
279.4
1,267.1
418.6
325.1
334.9
354.7
496.4
365.3
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection
23.5
57.1
889.5
62.8
63.3
17.2
55.1
77.6
67.5
Syphilis – congenital
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Syphilis < 2 years duration
1.1
6.6
5.1
5.3
4.8
3.1
10.1
3.8
6.6
Syphilis > 2 years or unspecified duration¶,§
4.3
5.8
83.3
4.4
6.3
2.3
9.6
10.5
7.7
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.1
0.0
0.2
0.0
0.0
0.1
0.0
0.1
Influenza (laboratory confirmed)
61.9
34.5
64.6
56.9
101.7
9.4
35.1
34.4
44.2
Measles
0.0
0.5
0.0
0.4
0.2
0.0
0.2
0.0
0.3
Mumps
1.1
1.8
0.0
1.1
0.0
0.8
0.1
1.5
1.0
Pertussis
39.5
27.4
47.6
73.1
33.1
68.7
41.9
52.9
44.7
Pneumococcal disease (invasive)
5.3
7.4
20.4
7.5
8.5
5.5
7.4
8.9
7.7
Poliomyelitis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
0.0
0.2
0.0
0.1
0.2
0.0
0.1
0.0
0.1
Rubella – congenital
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
Tetanus
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
1.1
NN
32.3
4.2
24.4
6.2
12.5
13.2
11.2
Varicella zoster (shingles)
21.3
NN
112.3
0.7
118.3
39.8
20.6
55.7
32.8
Varicella zoster (unspecified)
32.0
NN
1.7
104.8
8.2
18.0
46.8
48.8
58.1
Vectorborne diseases
Arbovirus infection (NEC)
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.1
Barmah Forest virus infection
1.1
7.3
285.7
72.5
5.6
1.6
1.7
59.4
27.1
Dengue virus infection
1.1
3.7
23.8
15.9
3.6
2.3
6.7
19.4
8.7
Japanese encephalitis virus infection
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.2
0.0
Kunjin virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
2.1
0.8
3.4
2.1
0.5
3.9
1.3
3.0
1.5
Murray Valley encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
0.0
10.8
122.5
52.1
8.7
0.8
2.4
59.7
22.9
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.0
0.0
0.4
0.0
0.0
0.0
0.0
0.1
Leptospirosis
0.0
0.2
3.4
2.8
0.0
0.0
0.1
0.2
0.7
Lyssavirus (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.2
0.0
0.0
0.0
0.0
0.8
0.0
0.3
Q fever
0.0
2.5
0.0
6.7
0.7
0.0
1.1
0.3
2.5
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
0.0
1.6
1.7
2.5
3.1
1.6
1.1
3.6
2.0
Leprosy
0.0
0.0
1.7
0.0
0.0
0.0
0.0
0.3
0.1
Meningococcal infection††
1.1
0.3
1.7
0.8
1.2
0.0
0.2
0.5
0.5
Tuberculosis
3.2
5.7
15.3
3.8
2.2
0.0
5.9
5.1
5.0

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Intelligence